These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20631185)

  • 1. Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF.
    Kells AP; Eberling J; Su X; Pivirotto P; Bringas J; Hadaczek P; Narrow WC; Bowers WJ; Federoff HJ; Forsayeth J; Bankiewicz KS
    J Neurosci; 2010 Jul; 30(28):9567-77. PubMed ID: 20631185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
    Johnston LC; Eberling J; Pivirotto P; Hadaczek P; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 May; 20(5):497-510. PubMed ID: 19203243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.
    Su X; Kells AP; Huang EJ; Lee HS; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Penticuff J; Eberling J; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 Dec; 20(12):1627-40. PubMed ID: 19671001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
    Kordower JH; Emborg ME; Bloch J; Ma SY; Chu Y; Leventhal L; McBride J; Chen EY; Palfi S; Roitberg BZ; Brown WD; Holden JE; Pyzalski R; Taylor MD; Carvey P; Ling Z; Trono D; Hantraye P; Déglon N; Aebischer P
    Science; 2000 Oct; 290(5492):767-73. PubMed ID: 11052933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys.
    Oiwa Y; Nakai K; Itakura T
    Neurol Med Chir (Tokyo); 2006 Jun; 46(6):267-75; discussion 275-6. PubMed ID: 16794346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys.
    Eberling JL; Kells AP; Pivirotto P; Beyer J; Bringas J; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 May; 20(5):511-8. PubMed ID: 19254173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
    Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
    J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys.
    Kordower JH; Herzog CD; Dass B; Bakay RA; Stansell J; Gasmi M; Bartus RT
    Ann Neurol; 2006 Dec; 60(6):706-15. PubMed ID: 17192932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation.
    Villadiego J; Méndez-Ferrer S; Valdés-Sánchez T; Silos-Santiago I; Fariñas I; López-Barneo J; Toledo-Aral JJ
    J Neurosci; 2005 Apr; 25(16):4091-8. PubMed ID: 15843611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
    Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
    Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
    BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion.
    McGrath J; Lintz E; Hoffer BJ; Gerhardt GA; Quintero EM; Granholm AC
    Cell Transplant; 2002; 11(3):215-27. PubMed ID: 12075987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of nigral neurons by GDNF-engineered marrow cell transplantation.
    Park KW; Eglitis MA; Mouradian MM
    Neurosci Res; 2001 Aug; 40(4):315-23. PubMed ID: 11463477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action.
    Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K
    Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trophic factor distribution predicts functional recovery in parkinsonian monkeys.
    Gash DM; Zhang Z; Ai Y; Grondin R; Coffey R; Gerhardt GA
    Ann Neurol; 2005 Aug; 58(2):224-33. PubMed ID: 16049934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
    Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
    Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
    Connor B
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.